CBX7 and prostate cancer: Interestingly, CBX7 seems to positively regulate miR-323: this can account for the reduced miR-323 expression in prostate cancer where CBX7 is drastically downregulated [38] and miR-323 has a tumor suppressor activity by targeting AdipoRI [39].